Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anucort HC in symptomatic internal hemorrhoids
NCT01913158Phase 2Completed
- Sponsor
- G&W Laboratories
- Start
- Oct 2013
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in internal hemorrhoids comparing Anucort-HC with Placebo (2 arms). Primary endpoint: Bleeding Cessation at 18 days. Started Oct 2013; status: completed.
02
Drugs
hydrocortisone
03
Conditions
internal hemorrhoids
Beyond the preview
Go deeper on NCT01913158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01913158.